{"type":"video","version":"1.0","html":"<iframe width=\"560\" height=\"315\" sandbox=\"allow-same-origin allow-scripts allow-popups allow-forms\" title=\"CSMU-Taiwan: Docking of Risankizumab-Derived scFv with IL-23 p19 Subunit (2025)\" src=\"https://video.igem.org/videos/embed/k7aqwDJ4P4VTuQagdQ1V1n\" style=\"border: none\" allow=\"fullscreen\"></iframe>","width":560,"height":315,"title":"CSMU-Taiwan: Docking of Risankizumab-Derived scFv with IL-23 p19 Subunit (2025)","author_name":"2025 Teams","author_url":"https://video.igem.org/video-channels/2025_teams","provider_name":"PeerTube","provider_url":"https://video.igem.org","thumbnail_url":"https://video.igem.org/lazy-static/thumbnails/d61953b4-09c4-407d-b364-3bef5493c7da.jpg","thumbnail_width":850,"thumbnail_height":480}